The future of Swedish and Danish life science

A Testa Center representative will be present at this event.

“Take the opportunity to join our panel discussions at The Future of Swedish & Danish Life Science:

• Pipeline of Swedish and Danish IMMUNO-ONCOLOGY therapies – challenges, possibilities and how to bring new medicines to market
• Leveraging investments in regional programs/research infrastructure for growth
• How to attract (and keep) talents and competences in the MVA-region?
• How can the virtual company model in start-up- and early phase drug development be further developed?
• How can the partnership with service providers in late stage drug development, IPO and market access program be further improved?”

Source: Swedishdanishlifescience.se

Share with colleagues!